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found to reflect alterations in adrenergic nerve function that have a critical
influence on the adverse outcome of patients with congestive heart failure
(CHF). Thia alteration has been shown to be of high prognostic value in
comparison with resting hemodynamic indicaa in end-stage CHF patients.
However,the comparison with another major prognostic index, peak exercise
oxY9enuptake (peak V02), has not yet been done.
We prospectively studied 93 consecutive ambuiatoty CHF patients (age
55 + 10 years) with an ejeetion fraction <45% (mean 25 & 10). Cardiac
MIBG uptake was measured as the heart to mediastinum activity ratio on
the planar image (10-min acquisition in the chest anterior wiew) obtained 4
h after a 111to 148 MBq IV injection of 1-123MIBG (H/M, mean 133 + 21%,
normal values: 192 + 42%). Peak V02 was measured during cycla axercise
(mean 20+ 6 ml/min/kg).
During a mean follow-up of 10 + 8 months, 10 patienta died and 22 had
heart transplantation. Peak VOp (p c 0.0001) and MIBG H/M (p= 0.02) were
predictive of death or transplantation by Cox univariate analysis. Using mul-
tivariate analysis, only peak V02 predicted outcome. When transplantation
events were censored, only peak V02, normalized either by body weightorby
pradieted values, emerged as predictor of outcome (p < 0.05). Kaplan-Meier
analysis confirmed the greater prognostic value of peak VOC+
We conclude that in this population of ambulato~ CHF patients, altered
adrenergic newe function has lower prognostic value than exercise capacity.
1940-991 M~~~ardialUptake of Radiol*beledAntimY~~in
Antibody Mirrors Histopathological Fibrosis in
Experimental Aortic Regurgitation
P.Lu, S.M. Goldfine, P.Zanzonico, E.M. Herrold, N. Magid, J.S. Borer. The
New YorkHospital, Cornell Medical Centec New York,NY USA
We have previously shown that (1) exuberant myocardial fibrosis invariably
accompanies, and may cause, myocyto/ysiswhen chronic experimental aor-
tic regurgitation (eAR) leads to heart failure (CHF) and (2) myocardial uptake
of In-ill-labeled antimyosin antibody (AA) in vivo is greater in chronic eAR
than in acute eAR or normal. To validate AA uptake as an index of fibrosis
in AR, we assessed relative heart AA concentration ([% injected dosa/gm]
x body wt) vs fibrosis score (Masson’s Trichrome stain and a 100 point grid
counting system) in 30 New Zealand white rabbits (19 with surgically induced
severe AR, 11 aham-operatedhorrnal) given 1-1.5 mCl In-ill-labeled AA
Fab Fragment (Myoscint) iv. and sacrificed46 hrlaterfortissue counting and
histology. Fibrosis score in AR animals sacrificed subacutely (3-5 wks of AR;
n = 11, 0 with CHF or subnormal ejeetion fraction IEFl) was 6.6 + 4.3 vs 6.2
+ 1.8 forage matched controls (n= 5, NS); in chronic eAR animals (98-128
wks of AR; n = 8, 0 with CHF/subnormal EF) score was 8.3 + 2.7 vs 5.3 +
3.8 for age-matched controls (n= 8, p < 0.1). Among AR and age-matched
control animals, relativa heart AA concentration correlated with fibrosis score
(r= 0.8, p = 0.03) despite absence of CHF or severe fibrosis. Thus in eAR,
myocardial uptake of In-ill-labeled AA quantitatively reflects myoeardial
fibrosis, probably pathogenic for myocardial damage, even when CHF is ab-
sent; therefore, external AA imaging may permit detection of fibrosis before
Cardiacfunctional and clinical deterioration in AR.
m940100 Effects of Transmyocardial LaserRevaacularizatlon on Myocsrdial Perfusion
R.J. March, A. Ali, M. Bouzoukis, B. Klontz, J.E. Parrillo, D.G. Caralis. Rush
Medical Col@a, Chicago, IL, USA
The effaets of Tranamyocardial Laser Revascularization (TMLR) on left ven-
tricular (LV) Myocardial Perfusion (MP) have not been thoroughly examined.
16 consecutive patients (pts), ten men and six women (age range 45-78
yra, mean 64) were followed at 3,6 and 12 month intewals following TMLR.
MP studies were obtained using IV dipyridamole over 4 min with 3.5 mCi of
Thallium-201 (Tl) given 3 min later. MP imaging was done both immediately
and at 3 hours following TI infusion. Finally, 1.5 mCi of TI was given and a
third set of images was obtainad. Ail images of the LV sagmenta: anterior,
lateral, inferior, posterior and septal ware scored on a scale of O-4+ by two
independent obsewera who were blinded as to the Iasad segments (O= nl, 2+
to 3+ = moderately severa ischemia, 4+= severe ischemia). There were no
deaths, myocardial infarctions or further revascularization procedures done
on these pts during their first year of follow-up.
?
8l\
$.s
3
2.5 \
MP improves during the first year after TMLR, and parallels the changes
observed in angina pectoris.
1940-101 \ Accuracy of Spiral Computed Tomography for
Identifying Internal Mammary Artary and
Saphanous Vein Bypaas Graft Patency
M,G. Engelmann, A. von Smekal, E. Kurzinger, B. Hofling, M. Reiser.
Ludwig-Maximilians Univerai~ Klinikum Grosshadem Munich, Germany
Background: Spiral computed tomography (SCT) is an particularly useful
imaging method for vascular structures, i.e. coronaty grafts. Prior investiga-
tions concentrated on evaluation of saphenous vein grafts after surgey. The
value of SCT in visualizing internal mammary bypass graft patency has not
been well studied. Hence the aim of this study was to determine the value of
high resolution SCTscanner in visualization both arterial and venous bypass
grafts two years after surgery. Methoda: Forty-nine patients (age 81.1 + 7.9
years, 45 men) who had undergone CABG procedure were examined by
SCT (Siemens Somatom plus 4) and’angiography 22.2 + 5.9 months after
surgery (n = 49). In total, 134 bypass grafts (42 IMA and 92 venous grafts)
were analyzed. With SCT contiguous data set of the heart was acquired
which allowed segmental and three-dimensional visualization of the length
of grafts. Resu/ts: The patency rate of the CABG, determined angiography
was 75.7% (IMA, n = 36/42) and 73.9% (venoue grafts n = 88/92). By SCT,
32 IMA and 64 venous grafts were diagnosed correctly as patent. Thus, the
sensitivity was 88.9% (IMA) and 94.1% (venous grafts). None of correctly
occluded venous grafts was diagnosed falsely patent by SCT (specificity
100%), where the specificity of IMA graft visualization was somewhat lower
(83.3%). The accuracy of SCT (predictive value for patency of a graft) was
86.1% (IMA) and 95.7% (venous CABG), respectively. Sensitivity, specificity
and accuracy did not differ significantly between IMA or venous grafts (p =
NS).
Conclusions: The recent generation of SCT scanner is able to assess the
coronary graft patency with high sensitivity, specificity and accuracy. Both,
saphenous vein grafts and IMA grafts can be assessed with an accuracy of
about 90%. SCT is a fast and non invaeive taehnique allowing the accurate
evaluation of graft patency in the long term,
I94O-102] Ar$thaPr$dictoraof Hard and Soft Eventa
Similar in Patiants with Stable CAD?
N. Nallamothu, E.R. Acio, S. Bala-Gupta, W. VanDecker, J. Heo,
A.E. Iskandrian. Allegheny University of the Health Sciences, Philadelphia,
PA, USA
This study examined the predictors of hard events (death and non-fatal
myoeardial infarction [Ml]) andsoftevents (late revascularization > 3months)
in 1007 pts with stable CAD who underwent coronary angiography and stress
SPECT perfusion imaging. There were 680 men and 327 women aged 61
+ 11 yeara. During a mean follow-up of 46 + 28 monthe, there were 159
hard events (67 deaths and 92 non-fatal Mls) and 195 soft events (PTCA
or CABG). Uni- and multi-variate Cox suwival analysis on important clinical,
stress, catheterization and SPECT variables identified the extent of the total
perfusion abnormality (fixed and reversible) as the best predictor of total
